Avastimab 400 mg Injection
  1. Home
  2. Pharma Products
  3. RPG Life Sciences Ltd
  4. Avastimab 400 mg Injection

Avastimab 400 mg Injection

Avastimab 400 mg Injection contains bevacizumab 400 mg, a monoclonal antibody used as an anticancer medicine. It works by inhibiting VEGF, which helps reduce the formation of blood vessels that supply tumors. The product is supplied as a 400 mg/16 mL solution for intravenous infusion.

BUY NOW

Category

Bevacizumab binds to vascular endothelial growth factor and inhibits its activity, reducing tumor-associated blood-vessel formation. Avastimab is used in specific treatment regimens for several cancers, including colorectal cancer, non-small-cell lung cancer, kidney cancer, and certain gynecological cancers. The 400 mg presentation contains 400 mg of bevacizumab in 16 mL, equivalent to 25 mg/mL. Avastimab 400 mg Injection is manufactured by RPG Life Sciences Ltd and is administered as a slow intravenous infusion by healthcare professionals.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 400 mg
Concentration 25 mg/mL
Pack Size 16 mL vial
Dosage Form Solution for infusion
Route of Administration Intravenous infusion

Product Also Known As

Avastimab 400 mg Injection, Avastimab 400 mg/16 mL, Avastimab 400 Injection, Avastimab Bevacizumab Injection, Bevacizumab 400 mg Injection, Bevacizumab 400 mg/16 mL